Holobeam
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
936 Roxbury Dr, Westbury, New York, 1159...Phone Number
(201) 445-2420Website
www.holobeamtech.comRevenue
<$5 MillionStock Symbol
HOOBIndustry
About Holobeam
Holobeam Technologies is a pioneer in medical holography, focusing on innovative solutions for cancer detection and treatment. The company is developing patented medical imaging and treatment products aimed at precision oncology, with the goal of significantly reducing cancer-related deaths. Their technologies promise earlier and more effective interventions, with preliminary positive results observed in preclinical studies. Holobeam is supported by government research grants and has recently secured $16 million in Series A funding to advance their research and development efforts.Explore more
Holobeam Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Holobeam
Compare insights from companies similar to Holobeam, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Holobeam Tech Stack
A closer look at the technologies used by Holobeam
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Holobeam
Sign Up For FreeTo access detailed company insights
Holobeam Technologies is a pioneer in medical holography, focusing on innovative solutions for cancer detection and treatment. The company is developing patented medical imaging and treatment products aimed at precision oncology, with the goal of significantly reducing cancer-related deaths. Their technologies promise earlier and more effective int... Read More
